UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________________________

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934

For the month of October, 2007

Commission File Number ________________


Novogen Limited
(Translation of registrant’s name into English)

140 Wicks Road, North Ryde, NSW, Australia
(Address of principal executive office)
___________________________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x   Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(l):

Note: Regulation S-T Rule 101 (b)( I) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule lO1(b)(7):

Note: Regulation S-T Rule l01(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule l2g3-2(b) under the Securities Exchange Act of 1934. Yes o   No x

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Novogen Limited
(Registrant)
/s/  Ron Erratt
Ronald Lea Erratt
Company Secretary
Date 26 October, 2007



The Manager Companies
Australian Stock Exchange
20 Bridge Street
SYDNEY NSW 2000

 
Dear Sir

Results of the Novogen Annual General Meeting

In accordance with Listing Rule 3.12.2 and Section 251AA of the Corporations Act the details of the resolutions and the proxies received in respect of each resolution are set out in the following summary.


Yours faithfully

Ron Erratt
Company Secretary
26 October, 2007
 
 


 
 
Novogen Limited
 
 
Proxy Summary
 
Annual General Meeting
 
26 October 2007
 
 
 
 
 
2
To adopt the Remuneration Report for the year ended 30 June 2007
 
 
 
 
 
 
 
The instructions given to validly appointed proxies in respect of the resolution were as follows:
 
In Favour
Against
Abstention
Proxy's discretion
 
16,344,350
1,086,047
727,004
1,432,311
 
 
 
 
 
 
The motion was carried on a show of hands as an ordinary resolution.
 
 
 
 
 
 
3
To re-elect Mr Geoffrey M Leppinus as a Director
 
 
 
 
 
 
 
The instructions given to validly appointed proxies in respect of the resolution were as follows:
 
In Favour
Against
Abstention
Proxy's discretion
 
16,887,595
547,823
723,483
1,430,811
 
 
 
 
 
 
The motion was carried on a show of hands as an ordinary resolution.
 
 
 
 
 
 
4
To adopt the amendments to Employee Share Option Plan
 
 
 
 
 
 
 
The instructions given to validly appointed proxies in respect of the resolution were as follows:
 
In Favour
Against
Abstention
Proxy's discretion
 
13,805,512
3,472,780
894,909
1,416,511
 
 
 
 
 
 
The motion was carried on a show of hands as an ordinary resolution.
 
 
 
 
 
 
5
To approve the Employee Share Option Plan under Rule 7.1 of the ASX Listing Rules
 
 
 
 
 
 
The instructions given to validly appointed proxies in respect of the resolution were as follows:
 
In Favour
Against
Abstention
Proxy's discretion
 
13,515,946
3,465,568
657,870
1,417,511
 
 
 
 
 
 
The motion was carried on a show of hands as an ordinary resolution.
 
 
 
 
 
 
6
To approve the Issue of Options to Christopher Naughton
 
 
 
 
 
 
 
The instructions given to validly appointed proxies in respect of the resolution were as follows:
 
In Favour
Against
Abstention
Proxy's discretion
 
12,552,759
4,202,324
845,040
1,416,511
 
 
 
 
 
 
The motion was carried on a show of hands as an ordinary resolution.
 
 
 
 
 
 
7
To approve the Issue of Options to Alan Husband
 
 
 
 
 
 
 
The instructions given to validly appointed proxies in respect of the resolution were as follows:
 
In Favour
Against
Abstention
Proxy's discretion
 
13,344,826
4,063,341
765,034
1,416,511
 
 
 
 
 
 
The motion was carried on a show of hands as an ordinary resolution.
 
 
 
 
 
 
Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Kazia Therapeutics Charts.
Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Kazia Therapeutics Charts.